Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MeCOVID: Melatonin for SARS-CoV-2 Prophylaxis
NCT04353128Phase 3Completed
- Sponsor
- Hospital La Paz Institute for Health Research
- Start
- Apr 2020
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of melatonin in coronavirus disease 2019 (COVID-19), sponsored by Hospital La Paz Institute for Health Research. Started Apr 2020; status: completed.
02
Drugs
melatonin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04353128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04353128.